Use of Non-Selective Beta Blockers (NSBB) in Cirrhotic Patients with Bacterial Infections is Associated with Lower Frequency of Sepsis, but not of Acute-On-Chronic Liver Failure (ACLF) or Survival. Results of a Prospective Study